DD144916A5 - Verfahren zur herstellung von pyrimidinverbindungen und ihren salzen - Google Patents

Verfahren zur herstellung von pyrimidinverbindungen und ihren salzen Download PDF

Info

Publication number
DD144916A5
DD144916A5 DD79214517A DD21451779A DD144916A5 DD 144916 A5 DD144916 A5 DD 144916A5 DD 79214517 A DD79214517 A DD 79214517A DD 21451779 A DD21451779 A DD 21451779A DD 144916 A5 DD144916 A5 DD 144916A5
Authority
DD
German Democratic Republic
Prior art keywords
general formula
group
compound
radical
atom
Prior art date
Application number
DD79214517A
Other languages
German (de)
English (en)
Inventor
Charon R Ganellin
Robert J Ife
David A A Owen
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of DD144916A5 publication Critical patent/DD144916A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD79214517A 1978-07-15 1979-07-16 Verfahren zur herstellung von pyrimidinverbindungen und ihren salzen DD144916A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7829999 1978-07-15

Publications (1)

Publication Number Publication Date
DD144916A5 true DD144916A5 (de) 1980-11-12

Family

ID=10498456

Family Applications (1)

Application Number Title Priority Date Filing Date
DD79214517A DD144916A5 (de) 1978-07-15 1979-07-16 Verfahren zur herstellung von pyrimidinverbindungen und ihren salzen

Country Status (20)

Country Link
US (4) US4305945A (fr)
EP (1) EP0007232A1 (fr)
JP (1) JPS5515499A (fr)
KR (1) KR830001247A (fr)
AR (1) AR226420A1 (fr)
AT (1) AT370728B (fr)
AU (1) AU528878B2 (fr)
CA (1) CA1114375A (fr)
DD (1) DD144916A5 (fr)
DK (1) DK293079A (fr)
ES (1) ES482448A1 (fr)
FI (1) FI792220A7 (fr)
GR (1) GR69252B (fr)
IL (1) IL57790A (fr)
NO (1) NO792337L (fr)
NZ (1) NZ191006A (fr)
PH (1) PH15979A (fr)
PL (1) PL217121A1 (fr)
PT (1) PT69886A (fr)
ZA (1) ZA793392B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151188B (fr) * 1978-02-13 1983-03-05 Smith Kline French Lab
AU527202B2 (en) * 1978-04-11 1983-02-24 Smith Kline & French Laboratories Limited 2-aminopyrimidones
ZA793392B (en) * 1978-07-15 1980-08-27 Smith Kline French Lab Isoureas and isothioureas
DK558181A (da) * 1981-01-30 1982-07-31 Smithkline Corp Fremgangsmaade til fremstilling af 3,5-diamino-1,2,4-triazoler
US4477663A (en) * 1981-02-06 1984-10-16 Smithkline Beckman Corporation Intermediates for preparing substituted pyrimidinones
US4620001A (en) * 1981-02-06 1986-10-28 Smithkline Beckman Corporation Chemical methods and intermediates for preparing substituted pyrimidinones
JPH0641454B2 (ja) * 1985-02-27 1994-06-01 日産化学工業株式会社 ピリダジノン誘導体
DE3532880A1 (de) * 1985-09-14 1987-03-26 Basf Ag 1,4-disubstituierte pyrazolderivate
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1223686A (en) 1967-02-24 1971-03-03 Ici Ltd Salts of pyrimidine derivatives and the use thereof as fungicides
US3980781A (en) * 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
US4218452A (en) * 1975-10-02 1980-08-19 Smith Kline & French Laboratories Limited Substituted 4-pyrimidone compounds, compositions and methods of use
US4145546A (en) * 1975-10-02 1979-03-20 Smith Kline & French Laboratories Limited 4-Pyrimidone compounds
GB1578219A (en) * 1975-12-01 1980-11-05 Smith Kline French Lab Isothioureas
MW5076A1 (en) * 1975-12-29 1978-02-08 Smith Kline French Lab Pharmacologicalle active compounds
US4154834A (en) * 1975-12-29 1979-05-15 Smith Kline & French Laboratories Limited Substituted isocytosines having histamine H2 -antagonist activity
IN151188B (fr) * 1978-02-13 1983-03-05 Smith Kline French Lab
ZA793392B (en) * 1978-07-15 1980-08-27 Smith Kline French Lab Isoureas and isothioureas

Also Published As

Publication number Publication date
ATA492279A (de) 1982-09-15
AT370728B (de) 1983-04-25
EP0007232A1 (fr) 1980-01-23
GR69252B (fr) 1982-05-11
AR226420A1 (es) 1982-07-15
US4439435A (en) 1984-03-27
NZ191006A (en) 1982-09-07
PL217121A1 (fr) 1980-06-16
NO792337L (no) 1980-01-16
IL57790A (en) 1984-01-31
US4639519A (en) 1987-01-27
PT69886A (en) 1979-08-01
US4305945A (en) 1981-12-15
PH15979A (en) 1983-05-16
IL57790A0 (en) 1979-11-30
AU4895479A (en) 1980-01-24
ZA793392B (en) 1980-08-27
KR830001247A (ko) 1983-04-29
DK293079A (da) 1980-01-16
CA1114375A (fr) 1981-12-15
JPS5515499A (en) 1980-02-02
AU528878B2 (en) 1983-05-19
FI792220A7 (fi) 1981-01-01
US4558128A (en) 1985-12-10
ES482448A1 (es) 1980-04-01

Similar Documents

Publication Publication Date Title
DE2211454C3 (fr)
DE3787384T2 (de) Antiarrhythmische Verbindungen.
DE2344779C3 (de) N-Cyan-N'-methyl-N''-${2-[(5-methyl-imidazol-4-yl)-methylthio]-äthyl}-guanidin, seine Salze mit Säuren und seine Verwendung als Histamin-H↓2↓-Receptor-Antagonist
DE3781845T2 (de) Benzimidazol-derivate.
DE3486009T2 (de) 5-pyridyl-1,3-thiazol-derivate, ihre herstellung und anwendung.
DD142052A5 (de) Verfahren zur herstellung von pyrimidonen
DE2147794A1 (de) Neue Triazole und diese enthaltende Zubereitungen
DD233374A5 (de) Verfahren zur herstellung von 2-(n-subst.-guanidino)-4-heteroarylthiazole
DE2406166A1 (de) Sulfoxide, ihre salze mit saeuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2643670C2 (de) 5-Benzyl-4-pyrimidon-Derivate, ihre Salze mit Säuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2322880C2 (de) 4-(Imidazolin-2-ylamino)-2,1,3-benzothiadiazole und Verfahren zu deren Herstellung
DD202293A5 (de) Verfahren zur herstellung von 2-guanidino-4-heteroarylthiazolen
DE2433625A1 (de) Harnstoff-derivate, verfahren zu ihrer herstellung und arzneimittel
DE2528639A1 (de) Harnstoff-derivate, verfahren zu ihrer herstellung und arzneimittel
DE2928842A1 (de) Pyrimidonderivate
CH631981A5 (en) Process for preparing novel derivatives of pyrimid-4-one and pyrimid-4-thione, and their salts with acids
DD149217A5 (de) Verfahren zur herstellung von pyrimidonderivaten
DD202291A5 (de) Verfahren zur herstellung von als histamin-h tief 1-rezeptor-antagonisten wirkenden pyrimidon-derivaten
DE2344833A1 (de) Guanidine, ihre salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DD144916A5 (de) Verfahren zur herstellung von pyrimidinverbindungen und ihren salzen
DE2411295A1 (de) Substituierte benzimidazol-2-carbamatderivate, verfahren zu deren herstellung und diese enthaltende zusammensetzung
CH645354A5 (de) Chinolyl-guanidine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mischungen.
DE2604056A1 (de) Thiocarbaminsaeure-derivate
DE1956891A1 (de) Chemische Verfahren und Produkte
DE2510860A1 (de) Harnstoff-derivate, verfahren zu ihrer herstellung und arzneimittel